Latest News on JHG

Financial News Based On Company


Advertisement
Advertisement

Should Value Investors Buy Janus Henderson Group ( JHG ) Stock?

https://www.zacks.com/stock/news/2791285/should-value-investors-buy-janus-henderson-group-jhg-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

3 Great Mutual Fund Picks for Your Retirement

https://www.zacks.com/stock/news/2791084/3-great-mutual-fund-picks-for-your-retirement
Take advantage of these top-ranked, best-performing and well-managed mutual funds to maximize your retirement portfolio returns.

Is Janus Henderson Enterprise Institutional ( JAAGX ) a Strong Mutual Fund Pick Right Now?

https://www.zacks.com/stock/news/2791005/is-janus-henderson-enterprise-institutional-jaagx-a-strong-mutual-fund-pick-right-now
Mutual Fund Report for ...

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

https://www.zacks.com/stock/news/2789868/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Galecto Announces Acquisition of Damora Therapeutics

https://www.globenewswire.com/news-release/2025/11/10/3184348/0/en/Galecto-Announces-Acquisition-of-Damora-Therapeutics.html
Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproliferative Neoplasms ...
Advertisement

Galecto Announces Acquisition of Damora Therapeutics - Galecto ( NASDAQ:GLTO )

https://www.benzinga.com/pressreleases/25/11/g48748098/galecto-announces-acquisition-of-damora-therapeutics
Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproliferative Neoplasms

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

https://www.zacks.com/stock/news/2786755/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

Ocugen Provides Business Update with Third Quarter 2025 Financial Results - Ocugen ( NASDAQ:OCGN )

https://www.benzinga.com/pressreleases/25/11/g48648368/ocugen-provides-business-update-with-third-quarter-2025-financial-results
European Medicines Agency ( EMA ) provided acceptability of a single U.S.-based trial for submission of a Marketing Authorization Application ( MAA )

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

https://www.globenewswire.com/news-release/2025/11/05/3181230/0/en/Ocugen-Provides-Business-Update-with-Third-Quarter-2025-Financial-Results.html
Conference Call and Webcast Today at 8:30 a.m. ET Conference Call and Webcast Today at 8:30 a.m. ET ...

Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

https://www.globenewswire.com/news-release/2025/11/04/3180181/0/en/Relmada-Therapeutics-Announces-Pricing-of-100-Million-Underwritten-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html
CORAL GABLES, Fla., Nov. 04, 2025 ( GLOBE NEWSWIRE ) -- Relmada Therapeutics, Inc. ( Nasdaq: RLMD, "Relmada" or the "Company" ) , a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications, today announced the pricing of its ...
Advertisement

Tharimmune makes $540M bet on Canton Coin in crypto treasury push

https://cointelegraph.com/news/tharimmune-540m-canton-coin-crypto-treasury-push
The biotech company's pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.

JHG or CG: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2783693/jhg-or-cg-which-is-the-better-value-stock-right-now
JHG vs. CG: Which Stock Is the Better Value Option?

Janus Henderson Q3 2025 Earnings Transcript

https://www.fool.com/earnings/call-transcripts/2025/10/31/janus-henderson-q3-2025-earnings-transcript/
Image source: The Motley Fool.Thursday, Oct. 30, 2025 at 9 a.m. ETChief Executive Officer - Ali DibadjContinue reading ...

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

https://www.zacks.com/stock/news/2782505/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?

Janus Henderson Group plc ( JHG ) Could Be a Great Choice

https://www.zacks.com/stock/news/2781760/janus-henderson-group-plc-jhg-could-be-a-great-choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Janus Henderson Group (JHG) have what it takes? Let's find out.
Advertisement

Janus Henderson Group plc ( JHG ) Surpasses Q3 Earnings Estimates

https://www.zacks.com/stock/news/2781172/janus-henderson-group-plc-jhg-surpasses-q3-earnings-estimates
Janus Henderson Group (JHG) delivered earnings and revenue surprises of +7.92% and -0.60%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

3 Technology Mutual Funds to Bet on for the Digital Future

https://www.zacks.com/stock/news/2781094/3-technology-mutual-funds-to-bet-on-for-the-digital-future
FSELX, KTCAX and JGLTX are three technology mutual funds that offer investors exposure to AI, semiconductors and digital innovation in 2025.

Securitize, BNY Mellon launch tokenized fund backed by structured credit

https://cointelegraph.com/news/securitize-bny-mellon-tokenized-fund-structured-credit
Securitize and BNY Mellon are bringing AAA-rated collateralized loan obligations onchain, with Grove planning a $100M anchor as institutional demand for tokenized assets grows.

Janus Henderson Group plc ( JHG ) Hit a 52 Week High, Can the Run Continue?

https://www.zacks.com/stock/news/2778828/janus-henderson-group-plc-jhg-hit-a-52-week-high-can-the-run-continue
Janus Henderson Group (JHG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

4 Financial Stocks to Bet on as Sector Momentum Builds

https://www.zacks.com/stock/news/2778735/4-financial-stocks-to-bet-on-as-sector-momentum-builds
As financials gain steam in 2025, stocks like Goldman Sachs, HCI Group, Interactive Brokers and Janus Henderson stand out for growth and earnings strength.
Advertisement

Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?

https://www.zacks.com/stock/news/2778649/are-these-3-top-ranked-mutual-funds-in-your-retirement-portfolio
Adding these three top-ranked, best-performing, and well-managed mutual funds to your retirement portfolio could maximize your returns.

Why Janus Henderson Group Stock Was Skyrocketing on Monday

https://www.fool.com/investing/2025/10/27/why-janus-henderson-group-stock-was-skyrocketing-o/
The company might be changing hands in the very near future.

Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday - Strive ( NASDAQ:ASST ) , American Bitcoin ( NASDAQ:ABTC )

https://www.benzinga.com/trading-ideas/movers/25/10/48434401/janus-henderson-avidity-biosciences-bridgebio-pharma-and-other-big-stocks-moving-higher-on-m
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Monday. Shares of Janus Henderson Group plc ( NYSE:JHG ) rose sharply during Monday's session after the company confirmed receiving a non-binding takeover proposal from Trian Fund Management for $46 per share.

3 Great Mutual Fund Picks for Your Retirement

https://www.zacks.com/stock/news/2777499/3-great-mutual-fund-picks-for-your-retirement
Take a look at these three top-ranked, best-performing and well-managed mutual funds if you're looking to maximize your retirement portfolio returns.

Analysts Estimate T. Rowe Price ( TROW ) to Report a Decline in Earnings: What to Look Out for

https://www.zacks.com/stock/news/2776441/analysts-estimate-t-rowe-price-trow-to-report-a-decline-in-earnings-what-to-look-out-for
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Advertisement

Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

https://www.zacks.com/stock/news/2776100/should-you-add-these-3-top-performing-mutual-funds-to-your-portfolio
Take advantage of these top-ranked, best-performing and well-managed mutual funds to maximize your retirement portfolio returns.

Janus Henderson Group plc ( JHG ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

https://www.zacks.com/stock/news/2775317/janus-henderson-group-plc-jhg-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release
Janus Henderson Group (JHG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SEI Investments ( SEIC ) Surpasses Q3 Earnings Estimates

https://www.zacks.com/stock/news/2774542/sei-investments-seic-surpasses-q3-earnings-estimates
SEI (SEIC) delivered earnings and revenue surprises of +4.00% and -0.17%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences ( NASDAQ:NERV )

https://www.benzinga.com/trading-ideas/movers/25/10/48338563/minerva-stock-rises-after-securing-200m-for-schizophrenia-drug-trial
Minerva Neurosciences Inc ( NASDAQ:NERV ) shares are climbing Tuesday after the company announced up to $200 million in funding to support development of roluperidone for schizophrenia.

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - ATAI Life Sciences ( NASDAQ:ATAI )

https://www.benzinga.com/pressreleases/25/10/g48316495/atai-life-sciences-announces-closing-of-public-offering-and-full-exercise-of-option-to-purchase-ad
NEW YORK and AMSTERDAM, Oct. 20, 2025 ( GLOBE NEWSWIRE ) -- atai Life Sciences ( NASDAQ:ATAI ) ( "atai" ) , a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced that, on October 20, 2025, the closing of its public offering ...
Advertisement

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

https://www.globenewswire.com/news-release/2025/10/20/3169848/0/en/atai-Life-Sciences-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-Option-to-Purchase-Additional-Common-Shares.html
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from the first Phase 3 clinical trial of BPL-003 Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations ...

Is Janus Henderson Balanced T ( JABAX ) a Strong Mutual Fund Pick Right Now?

https://www.zacks.com/stock/news/2772053/is-janus-henderson-balanced-t-jabax-a-strong-mutual-fund-pick-right-now
Mutual Fund Report for ...

Is Janus Henderson Small Cap Growth Alpha ETF ( JSML ) a Strong ETF Right Now?

https://www.zacks.com/stock/news/2772043/is-janus-henderson-small-cap-growth-alpha-etf-jsml-a-strong-etf-right-now
Smart Beta ETF report for ...

Atwood & Palmer Unload $34 Million of Palantir ( NASDAQ: PLTR ) Stock: Should Investors Sell Too?

https://www.fool.com/coverage/filings/2025/10/17/atwood-and-palmer-unload-usd34-million-of-palantir-nasdaq-pltr-stock-should-investors-sell-too/
Atwood & Palmer Inc. reported a significant reduction in its Palantir Technologies position, selling 211,505 shares for an estimated $34.28 million, based on the average price during Q3 2025, per its October 15, 2025, SEC filing.According to a filing with the Securities and Exchange Commission ...

American Express Q3 Earnings Beat Estimates on Rising Network Volume

https://www.zacks.com/stock/news/2771382/american-express-q3-earnings-beat-estimates-on-rising-network-volume
AXP delivers a 19% EPS jump and double-digit revenue growth in Q3 2025, fueled by record network volumes and resilient card fee income.
Advertisement

Make the Most of Your Retirement with These Top-Ranked Mutual Funds

https://www.zacks.com/stock/news/2770880/make-the-most-of-your-retirement-with-these-top-ranked-mutual-funds
You might want to consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio to maximize your returns.

JHG vs. KKR: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2770375/jhg-vs-kkr-which-stock-is-the-better-value-option
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Janus Henderson Group plc ( JHG Quick QuoteJHG - ) or KKR & Co. Inc. ( KKR Quick QuoteKKR - ) . But which of these two stocks offers value investors a better bang for their buck right now?

Should Janus Henderson Small Cap Growth Alpha ETF ( JSML ) Be on Your Investing Radar?

https://www.zacks.com/stock/news/2769838/should-janus-henderson-small-cap-growth-alpha-etf-jsml-be-on-your-investing-radar
Style Box ETF report for ...

Synchrony Q3 Earnings Beat Estimates on Improved Purchase Volume

https://www.zacks.com/stock/news/2769540/synchrony-q3-earnings-beat-estimates-on-improved-purchase-volume
SYF's Q3 earnings jump 47% on stronger purchase volume and efficiency gains, easily surpassing profit and revenue estimates.

3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio

https://www.zacks.com/stock/news/2768967/3-magnificent-mutual-funds-to-maximize-your-retirement-portfolio
Consider adding these three top-ranked, best-performing and well-managed mutual funds to your retirement portfolio if you are looking to maximize returns.
Advertisement

Inside the knotty economics of the world's most profitable ETF

https://www.ft.com/content/83e5a62f-3c94-4c96-97ca-c07e79935322
And why they might soon change ...

Is the Market Bullish or Bearish on Janus Henderson Group PLC? - Janus Henderson Group ( NYSE:JHG )

https://www.benzinga.com/insights/short-sellers/25/10/48211663/is-the-market-bullish-or-bearish-on-janus-henderson-group-plc
Janus Henderson Group PLC's ( NYSE:JHG ) short interest as a percent of float has fallen 15.1% since its last report. According to exchange reported data, there are now 2.59 million shares sold short, which is 3.43% of all regular shares that are available for trading.

Janus Henderson Group plc ( JHG ) Could Be a Great Choice

https://www.zacks.com/stock/news/2768522/janus-henderson-group-plc-jhg-could-be-a-great-choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Janus Henderson Group (JHG) have what it takes? Let's find out.

AXP Gains Edge as RewardPay Debuts First-Ever Tax Pooling Rewards

https://www.zacks.com/stock/news/2768554/axp-gains-edge-as-rewardpay-debuts-first-ever-tax-pooling-rewards
American Express taps RewardPay's new tax pooling system to turn business tax payments into reward-earning, cash flow-friendly transactions.

Best Income Stocks to Buy for Oct. 14th

https://www.zacks.com/commentary/2768292/best-income-stocks-to-buy-for-oct-14th
GSL, JHG and JXN made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 14, 2025.
Advertisement

Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity

https://www.benzinga.com/pressreleases/25/10/g48193060/kailera-therapeutics-announces-600-million-series-b-financing-to-further-advance-pipeline-of-next-
- Financing led by new investor Bain Capital Private Equity with participation from new and existing investors to support continued development of a differentiated, late-stage portfolio of obesity treatments -

Is Janus Henderson Enterprise T ( JAENX ) a Strong Mutual Fund Pick Right Now?

https://www.zacks.com/stock/news/2767150/is-janus-henderson-enterprise-t-jaenx-a-strong-mutual-fund-pick-right-now
Mutual Fund Report for ...

Semiconductor Sales Soar on Continued Demand: 3 Mutual Funds to Buy

https://www.zacks.com/stock/news/2766310/semiconductor-sales-soar-on-continued-demand-3-mutual-funds-to-buy
Surging semiconductor sales driven by AI and global demand make JNGTX, KTCAX and PRSCX standout mutual fund picks for investors.

Make the Most of Your Retirement with These Top-Ranked Mutual Funds

https://www.zacks.com/stock/news/2765165/make-the-most-of-your-retirement-with-these-top-ranked-mutual-funds
These three top-ranked, best-performing and well-managed funds can help you maximize your retirement portfolio returns.

INSPIRION Sells Off Its Entire Stake in the iShares AAA CLO Active ETF

https://www.fool.com/coverage/filings/2025/10/08/inspirion-sells-off-its-entire-ishares-aaa-clo-active-etf-stake/
On October 6, 2025, INSPIRION Wealth Advisors, LLC reported selling out of BlackRock ETF Trust II - iShares AAA CLO Active ETF ( NASDAQ:CLOA ) , an estimated $22.62 million transaction.According to a filing with the Securities and Exchange Commission dated October 6, 2025, INSPIRION Wealth ...
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement